SPIE Medical Imaging 2014 Workshop: Commercialization of Medical Research. Guy Shechter Philips Healthcare
|
|
- Griffin Warner
- 6 years ago
- Views:
Transcription
1 SPIE Medical Imaging 2014 Workshop: Commercialization of Medical Research Guy Shechter Philips Healthcare
2 A look back to 2004, a personal story: Prospective motion correction of X-ray images for coronary interventions
3 University Tech Transfer Office: Provisional patent application but bring us an interested vendor. Just because we can do it, doesn t mean we should do it. There may exist other means to the same end. What s it going to cost and who s going to pay for it?
4 Pay for it? It s just a small software mod Quality systems Regulatory Evidence development Market education
5 Value Proposition Call it a value proposition, a unique selling point, whatever it is, you need to clarify what you do, who you do it for and what makes it different from everyone else into a simple, clear believable statement Marketing Assassin Blog
6 Complexity of a value proposition in healthcare Multiple stakeholders Patient Physician Hospital Administration (ie. CFO, purchasing) Payer Changes to clinical pathways may upset the balance Pursuit of the Triple Aim (Donald Berwick) Improving the experience of care Improving the health of populations Reducing the per-capita costs of healthcare
7
8 Obstacles to the Pursuit of the Triple Aim Supply driven demand. New technology with limited impact on outcomes. Physician-centric care. Little or no foreign competition. Little appreciation of system knowledge among clinicians. Transparency in quality metrics. Accurate cost accounting.
9 The Role of an Integrator Only a single organization (not a market dynamic), can induce coordinative behavior among health service suppliers to work as a system for the defined population. Involving individuals and families Strengthen the role of primary care teams / medical home Increase preventive behavior Allocate resources within the defined population Define, measure, and make transparent the costs of care Approach new technologies and capital investments with skepticism Deliver care that is evidence-based and highly reliable
10 The Triple Aim Paradox? Interdependent goals: Changes pursuing any one goal can affect the other two, sometimes negatively and sometimes positively. These changes may occur at different times. Should your business focus on one, two or all three goals? Principal-agent problem: From the viewpoint of a national entity, the Triple Aim is essential. From the viewpoint of an individual actor responding to market forces, pursuing all three aims at once in not in their immediate self interest. Should your business focus on the principal or the agent?
11 Medical Regulatory Is it a medical device? Shantanu Nundy, et al. Mobile phone diabetes project led to improved glycemic control and net savings for Chicago plan participants. Health Affairs 2014; 33(2):
12 Medical Regulatory Class I, II, or III 510(k) vs. PMA Regulatory clearance/ approval allows one to market a product, but doesn t guarantee market adoption. Barbara Buch. FDA Medical Device Approval: Things you didn t learn in medical school or residency. Am J Orthop. 2007; 36(8):
13 Evidence Development Start planning for both regulatory and market acceptance The required level of evidence will be decided by the one in need of convincing. Efficacy Does X cause an effect in ideal situations? Homogenous test groups. Subjects who deviate from a protocol may be excluded from analysis. Effectiveness Does X work in the real world? Heterogeneous test groups. All subjects might be included in the analysis based on an intent to treat.
14
Data Transparency and Quality Metrics
Data Transparency and Quality Metrics Ann Ferriter Division of Analysis and Program Operations Office of Compliance Center for Devices and Radiological Health Why are we interested in transparency? What
More informationRe: Docket No. 2006D-0347, Federal Register: July 26, 2007 (Volume 72, Pages )
1201 Maryland Avenue SW, Ste. 900 Washington, DC 20024 August 27, 2007 BY ELECTRONIC DELIVERY Division of Dockets Management (HFA-305) Food and Drug Administration 56350 Fishers Lane Room 1061 Rockville,
More informationCustomer Relationship Management (CRM) BE IT-B Shital H. More
Customer Relationship Management (CRM) 1 Outline Definition of CRM Importance of CRM to General Managers Statistics Industry leaders Success stories Case Study MU Healthcare System Best Practices Lessons
More informationSzabolcs Barotfi Ph.D.
Szabolcs Barotfi Ph.D. Manufacturer: Bayer Withdrawn in 2001 (4 years after registration) Financial loss: 1.2 bn $ Manufacturer: MSD Withdrawn in 2004 (5 years after registration) Financial loss: 2 bn
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationDeveloping Drugs for Rare Diseases: Patient Advocacy s Perspective. Kristina Bowyer Executive Director, Patient Advocacy
Developing Drugs for Rare Diseases: Patient Advocacy s Perspective Kristina Bowyer Executive Director, Patient Advocacy February 5, 2018 An Advocacy Perspective Why develop drugs for Rare Disease? What
More informationMay 24, Dear Quality Use Case Team:
May 24, 2007 for Health Information Technology Attention: Quality Use Case Team Mary Switzer Building 330 C Street, S.W. Suite 4090 Washington, DC 20201 Dear Quality Use Case Team: The American Health
More informationTHAF Fellows Program. Engaging Board and Community Members in Quality/Patient Safety Initiatives. Ini
THAF Fellows Program Engaging Board and Community Members in Quality/Patient Safety Initiatives Kimberly McNally, MN, RN, BCC President, McNally & Associates Ini 2 Today s session Indicators of an engaged
More informationService vs. Value-Based Segmentation: Which Medtech Business Strategy Will Prevail?
Service vs. Value-Based Segmentation: Which Medtech Business Strategy Will Prevail? Medical device companies are considering services or value-based segmentation strategies to differentiate from the competition.
More information2018 Data Science Summit: The Economics Of Artificial Intelligence In Healthcare
May 30, 2018 2018 Data Science Summit: The Economics Of Artificial Intelligence In Healthcare Making AI Work In Clinical Practice Bibb Allen, MD FACR Chief Medical Officer ACR Data Science Institute OVERVIEW
More informationReal World Evidence Generation in the 21 st Century: National Evaluation System for health Technology (NEST)
Real World Evidence Generation in the 21 st Century: National Evaluation System for health Technology (NEST) Bill Murray, President & CEO IDEAL Conference Presentation May 5, 2017 1 www.mdic.org Vision
More informationIssues in Clinical Trial Designs for Devices
Issues in Clinical Trial Designs for Devices Soma Kalb, PhD Director, Investigational Device Exemption (IDE) Program Office of Device Evaluation Center for Devices and Radiological Health FDA Clinical
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org June 6, 2008 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville, MD
More informationPay-for-performance has emerged as a leading strategy
SALES & MARKETING INSIGHTS Medical Device Strategies for Competing in a Pay for Performance Future Pete Masloski Pay-for-performance has emerged as a leading strategy for improving quality and reducing
More informationKey Activities. Ofer Reizes, Ph.D. Skills Development Director
Key Activities Ofer Reizes, Ph.D. Skills Development Director 1 Key Activities Core Question: What key activities required for your Value Propositions? Key Partners Key Activities Key Resources Value Proposition
More informationProduct Quality Outcomes Analytics Update
1 Product Quality Outcomes Analytics Update 2 Car Buying Parameters 1 2 Safety. Effectiveness 5 Usability 6 Availability 3 Reliability 7 Compatibility 4 Satisfaction 3 How Do You Buy Your Car? Consumer
More informationCOCIR CT MANUFACTURERS VOLUNTARY COMMITMENT REGARDING CT DOSE OPTIMIZATION Annual Report
COCIR CT MANUFACTURERS VOLUNTARY COMMITMENT REGARDING CT DOSE OPTIMIZATION 2015 Annual Report Preamble In 2010 discussions took place between COCIR and the Heads of European Radiation Competent Authorities
More informationThe Path to Clinical Enterprise Maturity DEVELOPING A CLINICALLY INTEGRATED NETWORK
The Path to Clinical Enterprise Maturity DEVELOPING A CLINICALLY INTEGRATED NETWORK dhgllp.com/healthcare Kevin Locke PRINCIPAL Kevin.Locke@dhgllp.com 330.606.4699 Michael Strilesky SENIOR MANAGER Michael.Strilesky@dhgllp.com
More informationGEMS: A NEW IDEA FOR QUALITY IMPROVEMENT
GEMS: A NEW IDEA FOR QUALITY IMPROVEMENT Prof. Gopal K Kanji Kanji Quality Culture Ltd., Sheffield Technology Parks, Arundel Street, Sheffield, S1 2NS, England, UK; tel: +44 114 2212003, e-mail: quality@gopal-kanji.com
More informationMichael Malone, MD Kellie Flood, MD Kevin Foley, MD October 15, 2015
Basics of Writing a Business Plan Michael Malone, MD Kellie Flood, MD Kevin Foley, MD October 15, 2015 Background Requests for business plans from physicians are increasing as reimbursement shrinks and
More informationMay 9, Meeting Summary. Facilitating Antibacterial Drug Development
May 9, 2012 Meeting Summary Facilitating Antibacterial Drug Development Origins of the Current Public Health Crisis of Antibacterial Resistance Antibacterial drugs play a critical role in the ability to
More informationThe Promise of Data-Driven Healthcare
The Promise of Data-Driven Healthcare MegaTrends for 2018 and Beyond February 27, 2018 Presenters 1 Valerie Barton, Managing Director Valerie oversees Manatt s data and analytics capability. She works
More informationCOCIR CT Manufacturers Voluntary Commitment Regarding CT Dose 2014 Annual Report
Preamble COCIR CT Manufacturers Voluntary Commitment Regarding CT Dose 2014 Annual Report This 2 nd Annual Report defines the COCIR CT manufacturers voluntary commitment to HERCA as a result of the meeting
More informationImproving Healthcare Performance through Analytics and Cultural Transformation
About the Organization OSF Healthcare Pioneer ACO Facilities in Illinois and Michigan 11 Hospitals 108 Locations Serving nearly 700,000 Patients 2 Pursuing Clinical and Operational Excellence Analysis
More informationEvaluation & Decision Guides
SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM Evaluation & Decision Guides 2014 Revision (v3) New ideas & Improvements Department of Surgery Evidence Decision Support Program Resource
More informationLeveraging Internal Audit and Corporate Compliance for Effective Risk Management
Leveraging Internal Audit and Corporate Compliance for Effective Risk Management April 18, 2016 Don Sinko Chief Integrity Officer Cleveland Clinic Agenda Cleveland Clinic Integrity Office Model The 3 Lines
More informationMoving to Implementation
Care by Design Every system delivers exactly the results it is designed to give Moving to Implementation NHS Next Stage Review... A Perspective from Angie Nisbet, Director, Care by Design LTD ... the most
More informationUniversità Cattolica del Sacro Cuore
Università Cattolica del Sacro Cuore The role of Regulatory Affairs in drug development Francesco Mazza, Director of Legal, Fiscal & Compliance Affairs in Farmindustria Rome, May 12 2017 Who we are Who
More informationUsing Segmentation to Serve Up the Optimal Website Experience
Understanding User Intent Becki Dilworth Vice President of Digital Strategy Bridgeline Digital Chris Hachey E-Commerce Manager PODS Enterprises 1 Understanding User Intent Using Segmentation to Serve Up
More informationAligning Quality Measures across Payers
Aligning Quality Measures across Payers Prepared by SHADAC for the State Innovation Models (SIM) program under contract with NORC at the University of Chicago. SIM is funded by the Center for Medicare
More informationDocket No. FDA-2011-D-0215 Draft Guidance for Industry and FDA Staff on In Vitro Companion Diagnostic Devices
VIA Electronic Submission: http://www.regulations.gov Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: Docket No. Draft Guidance
More informationTHE FUTURE OF THE REVENUE CYCLE. A survey of provider executives about the next generation of revenue cycle management
THE FUTURE OF THE REVENUE CYCLE A survey of provider executives about the next generation of revenue cycle management OVERVIEW 1 Survey At-a-Glance 2 RCM Technology Trends/EHRs 3 4 Revenue Integrity Trends
More informationNOTABLE INDUSTRY TRENDS TO WATCH
IDN SUMMIT NOTABLE INDUSTRY TRENDS TO WATCH Avalere published their 2016 trends we look GREAT! Political focus on the cost of and access to specialty drugs and biologics will continue Patient engagement
More informationUsing local RWD to drive global therapeutic advancements.
Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those
More informationTeaching Others About Home Infusion Therapy: Strategies and Resources to Prove Your Value
Teaching Others About Home Infusion Therapy: Strategies and Resources to Prove Your Value Presented by: Kelly Aldridge, Regional Vice President of Sales and Marketing, Home Solutions, Northfield, NJ Top
More informationNEXT GENERATION REVENUE CYCLE
NEXT GENERATION REVENUE CYCLE Participating In Today s Webinar You have joined today's Webinar listening through your computer's speaker system by default. If you would like to call in using the phone,
More informationUPMC POLICY AND PROCEDURE MANUAL
SUBJECT: Value Analysis Program DATE: November 8, 2013 I. POLICY UPMC POLICY AND PROCEDURE MANUAL POLICY: HS-MM0302 * INDEX TITLE: Supply Chain Management It is the policy of UPMC to provide a single,
More informationOff-Label Use Congress and FDA must balance: The need to regulate manufacturer promotion of off-label use of devices; and The need for and availabilit
Off-Label Use Versus Clinical Trial Use of Devices: FDA Regulatory Issues Neil F. O Flaherty Principal Olsson Frank Weeda Terman Bode Matz PC Off-Label Use Uses that do not appear in a device s FDA-approved
More informationMaternity Watch Workbook: Improving Patient Outcomes by Creating Cultures of Early Detection and Response*
Maternity Watch Workbook: Improving Patient Outcomes by Creating Cultures of Early Detection and Response* This workbook and the companion guide are designed to serve as a resource to Project Team Leaders
More informationWorkshop on Access to and Uptake of Biosimilar Medicinal Products
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Consumer, Environmental and Health Technologies Biotechnology and Food Supply Chain Workshop on Access to
More informationImproving the Patient Experience Across the Revenue Cycle
Improving the Patient Experience Across the Revenue Cycle A closer look at patient centered approach to scheduling, pre-arrival, point-ofservice functions, and move towards a single billing office November
More informationNCI Supplier Services
Driving Business Development Ideas Into Practice Since 1986 January 29, 2007 NCI Supplier Services Consulting Group Solution Overview The Consulting Group of NCI Supplier Services (NCISS), supports the
More information2015 THROUGH RESULTS INTEGRATED THINKING THE BENEFITS OF INTEGRATED REPORTING <IR>
IFAC CREATING GLOBAL VALUE SMP FOR SURVEY: SMEs 2015 THROUGH RESULTS INTEGRATED THINKING THE BENEFITS OF INTEGRATED REPORTING Exposure Drafts, Consultation Papers, and other IFAC publications are
More informationA New Era of Clinical Diagnostics: How the Business Model is Changing.
A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September
More informationDefining the true market
Defining the true market Case study: How real-world data and outcomes improved a major pharmaceutical company s launch strategy Cardinal Health Specialty Solutions Competing in a crowded marketplace A
More informationSustainability Toolkit and Learning Collaborative PREPARED FOR BMS FOUNDATION GRANTEE SUMMIT APRIL 11, 2018
Sustainability Toolkit and Learning Collaborative PREPARED FOR BMS FOUNDATION GRANTEE SUMMIT APRIL 11, 2018 Introduction Organizational reflection Input for learning collaborative Why is the system relevant
More informationThe Theranos 483s. What can we learn? David Amor, MS, CQA Principal, Medgineering
The Theranos 483s. What can we learn? David Amor, MS, CQA Principal, Medgineering www.medgineering.com david@medgineering.com @Medgineering The good. The bad and the ugly. What can we learn? 2006. The
More informationMedicare Advantage risk adjustment: How deep is the well?
Medicare Advantage risk adjustment: How deep is the well? With increasing regulation and focus on quality, comprehensive risk and quality programs are more important than ever. Whether you re engaging
More informationThe Art of Putting It Together STANDARDIZE PROCESSES BEFORE CONSOLIDATING REVENUE CYCLE OPERATIONS
STANDARDIZE PROCESSES BEFORE CONSOLIDATING REVENUE CYCLE OPERATIONS STANDARDIZE PROCESSES BEFORE CONSOLIDATING REVENUE CYCLE OPERATIONS By Robert Parris, managing director, and Melanie Schoenvogel, senior
More informationEXPANDED ACCESS PROGRAMS
EXPANDED ACCESS PROGRAMS PRACTICAL OPERATIONAL CONSIDERATIONS While patient demand for expanded access is growing, a clear consensus has yet to emerge on the best way to address this demand. Debate continues
More informationDisruption, Reinvention & Growth
Disruption, Reinvention & Growth IT Opportunities in Healthcare Transformation TAG Market Insights Analyst Conference April 29, 2015 Focus Points Overview of Healthcare Transformation Top Health IT Trends
More informationDEFINING PAYER TYPES FOR SUCCESSFUL MARKET ACCESS
DEFINING TYPES FOR SUCCESSFUL MARKET ACCESS THE GROWING GAP BETWEEN FUNDING AND MEDICAL COSTS Healthcare payer organisations worldwide are focused on managing the gap between funding and medical costs,
More informationNot Happy with Pharmacy Research? Let s Build a List of Research Priorities Together!
Not Happy with Pharmacy Research? Let s Build a List of Research Priorities Together! AMCP Research Prioritization Initiative (RPI) Disclaimer Organizations may not re use material presented at this AMCP
More informationPOSITION DESCRIPTIONS
Chief Executive Officer Responsible for planning, directing, coordinating and controlling the overall operations of the organization and subsidiaries. Directs short and long-range functions including development
More informationREVENUE CYCLE TECHNOLOGY TRENDS
REVENUE CYCLE TECHNOLOGY TRENDS A survey of provider executives about revenue cycle IT budgets, EHRs, and consumer self-pay November 2018 Lead. Solve. Grow. HFMA/Navigant Survey At-a-Glance According to
More informationAccess Viewpoint FDA DRAFT GUIDANCE FOR PAYER COMMUNICATIONS: INSIGHTS AND IMPLICATIONS
Access Viewpoint FDA DRAFT GUIDANCE FOR PAYER COMMUNICATIONS: INSIGHTS AND IMPLICATIONS INTRODUCTION In January 2017, the FDA released draft guidance* Drug and Device Manufacturer Communications with Payors,
More informationA Framework for Comprehensive Assessment of the Value of Diagnostic Tests
A Framework for Comprehensive Assessment of the Value of Diagnostic Tests Chandra N. Branham, JD VP, Payment & Health Care Delivery Policy AdvaMed/AdvaMedDx October 18, 2017 Overview AdvaMed s Framework
More informationControl Costs and Increase Employee Engagement With Consumer Advantage
Control Costs and Increase Employee Engagement With Consumer Advantage Engage Employees Faced with rising healthcare costs, employers are turning to consumer-driven strategies to provide more cost-efficient
More informationHealthcare s New Change-Maker: The CFO
The role of hospital chief financial officer has changed dramatically over the last 50 years. No longer simply responsible for managing the hospital s finances, today s CFO is a change agent, an indispensable
More informationPolicy principles for a competitive healthcare environment
Policy principles for a competitive healthcare environment Pharmaceutical Research and Development Industry Malta Association (PRIMA) PRIMA is an affiliate of the European Federation of Pharmaceutical
More informationPolicies Approved by the 2018 ASHP House of Delegates
House of Delegates Policies Approved by the 2018 ASHP House of Delegates 1801 Unit Dose Packaging Availability To advocate that pharmaceutical manufacturers provide all medications used in health systems
More information3. Why is California taking the lead in this area? 4. Is this just a California initiative? Aren t ACOs important throughout the country?
Integrated Healthcare Association (IHA) and Pacific Business Group on Health (PBGH) Partner on Commercial ACO Measurement & Benchmarking Initiative FREQUENTLY ASKED QUESTIONS 1. What is the Commercial
More informationTHE HEALTHCARE SUPPLY CHAIN LEADER OF THE FUTURE
THE HEALTHCARE SUPPLY CHAIN LEADER OF THE FUTURE BACKGROUND Organizations are finding it increasingly difficult to recruit and retain supply chain expertise and leadership, particularly as the delivery
More informationNEUROENDOVASCULAR TRIALS
1 NEUROENDOVASCULAR TRIALS Understanding your Research Role in Stroke and Device Trials Tuesday, June 09, 2015 2 Biography Christy Anton is a Clinical Research Coordinator at Rush University Medical Center.
More informationWhat CEO s Want 2017
What CEO s Want 2017 Today s Presenter: Jeoff Burris Principal, Advanced Purchasing Dynamics >30 years manufacturing purchasing experience Founded APD in 2004 Helps clients make their investment in purchasing
More informationOptum One. The Intelligent Health Platform
Optum One The Intelligent Health Platform The Optum One intelligent health platform enables healthcare providers to manage patient populations. The platform combines the industry s most advanced integrated
More informationA UNSPSC Success Story. University Health Care System Augusta, Georgia
A UNSPSC Success Story University Health Care System Augusta, Georgia My first day on the job, my boss told me to just pay attention to coronary stents and spinal implants. I immediately discovered that
More informationGetting around the North American b2b market successfully Len Monheit, Executive Director, Engredea
Getting around the North American b2b market successfully Len Monheit, Executive Director, Engredea Presentation Outline Current news Market numbers Economics Culture Supply, quality issues (inc. GMP)
More informationMDM offers healthcare organizations an agile, affordable solution To deliver high quality patient care and better outcomes
MDM offers healthcare organizations an agile, affordable solution To deliver high quality patient care and better outcomes Many healthcare organizations are struggling with rising costs and inconsistent
More informationHow did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949
ICH GCP Overview What is ICH? ICH is a joint initiative involving both the regulators and the industry as equal partners in the scientific and technical discussions of the testing procedures which are
More informationToxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development
Toxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development No. 1 of 10 1. regulates all the drugs products manufactured and sold in the USA. (A) EMEA (B) IND (C) FDA (D) NDA (E) OSHA
More informationBusiness Analyst, Waitemata Central Hospital Operations
Date: December 2016 Job Title : Business Analyst, Waitemata Central Department : Hospital Services Location : Waitemata District Health Board sites Reporting To : Clinical Nurse Director, Waitemata Central
More informationSection I: Pharmaceuticals and Medical Devices
SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical
More informationPRE-CONFERENCE MEDICAL WRITING AND COMMUNICATIONS BOOT CAMP
PRE-CONFERENCE MEDICAL WRITING AND COMMUNICATIONS BOOT CAMP Wednesday, October 24th, 2018 Come prepared for dynamic workshops as you learn with some of the brightest minds in the field! 8:00 AM 9:00 AM
More informationProject Destiny Summary
Project Destiny Summary The American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), and the National Community Pharmacists Association (NCPA) have joined together
More informationStrategic approaches to Industry 4.0 in middle-income countries. Fernando Santiago Research and Industrial Policy Officer, UNIDO
Strategic approaches to Industry 4.0 in middle-income countries Fernando Santiago Research and Industrial Policy Officer, UNIDO Agenda Proposed dimensions to understand Industry 4.0 Research questions
More informationPlanning for Successful Medical Device Reimbursement:
Planning for Successful Medical Device Reimbursement: So Your Device Is Cleared, By Tiffini Diage, MPH Health Economics NAMSA White Paper Key Considerations for Targeting Success of Medical Device Sales
More informationWeaving an Interconnected Web of Data Sharing Networks
Weaving an Interconnected Web of Data Sharing Networks Presented by Dave Cassel, Director of Carequality An initiative of 1 2016 Copyright The Sequoia Project. All rights reserved. The Challenge What if
More informationSummary of the Actions of the ASHP House of Delegates. June 3 and 5, 2018
Summary of the Actions of the ASHP House of Delegates June 3 and 5, 2018 The House of Delegates Ultimate authority over ASHP professional policies One annual session consisting of 4 meetings: 2 meetings
More informationHow to Create a Regional Presence with Referral Relationships Gaining Market Share in Competitive Tertiary Markets
How to Create a Regional Presence with Referral Relationships Gaining Market Share in Competitive Tertiary Markets Article printed permission of Strategic Health Care Marketing, September 2003 by Kriss
More informationPhilips Healthcare Accelerate! Transformation. Greg Sebasky, Executive Vice President Business Transformation, Philips Healthcare
Philips Healthcare Accelerate! Transformation Greg Sebasky, Executive Vice President Business Transformation, Philips Healthcare 1 Key takeaways Accelerate! is a comprehensive program impacting all of
More informationCurrent Trends at FDA: Implications for Data Requirements
Introduction The environment surrounding medical device regulation in the United States has always been rigorous, but recent events including well-publicized quality issues associated with implantable
More informationNext Steps in Sustainable Purchasing:
Next Steps in Sustainable Purchasing: Opportunities to Build on Environmentally Preferred Purchasing Programs Dan Streit About WECC Nonprofit founded in 1980 National leader in the design and implementation
More informationGovernment of Saskatchewan - Standing Committee on Human Services Organ and Tissue Donation September 13 th, 2016
Government of Saskatchewan - Standing Committee on Human Services September 13 th, 2016 Maximizing Donor Potential in Saskatchewan? The following characteristics of a high performing donation system were
More informationHEALTH POLICY AND DRUG PRICING: A RESEARCHER S PERSPECTIVE
HEALTH POLICY AND DRUG PRICING: A RESEARCHER S PERSPECTIVE NATASHA KEKRE, MD, MPH, FRCPC NOV 16, 2016 www.ohri.ca WHY THIS MATTERS TO ME I am a hematologist in Ottawa with 75% dedicated time for research
More informationSirtex Medical Limited
Sirtex Medical Limited Market Update 2011 Half Year Results Gilman Wong CEO Darren Smith CFO 9-10 March 2011 SIR-Spheres is a registered trademark of Sirtex SIR-Spheres Pty Ltd. Understanding the Sirtex
More informationPerformance Excellence
Performance Excellence Leadership and Workforce Focus February 3, 2012 Topics Performance Excellence Expectations of Examiners Criteria Review Site Visit Interviews Strengths Opportunities for Improvement
More informationBetsi Cadwaladr University Health Board Third Sector Strategy
Introduction The third sector is diverse in the range of population groups it serves and types of services it provides. This diversity is at the heart of the strength and value of the sector. The depth
More informationMarket Analysis & Segmentation Bioshares Biotech Summit July Duncan Ross Managing Director & CEO
Market Analysis & Segmentation Bioshares Biotech Summit July 2016 Duncan Ross Managing Director & CEO 1 Disclaimer This presentation has been prepared by AtCor Medical Holdings Limited (AtCor or the Company)solely
More informationJOB DESCRIPTION. The appointment is full time and will be for an initial 2 year period which could be extended.
JOB DESCRIPTION POST TITLE: REPORTING TO: GRADE: LOCATION: HOURS: Programme Lead Patient Safety Director of Programmes, Change & Performance Management tbc 10 Greycoat Place, London SW1 1SB 37.5 hours
More informationCanadian Blood Services: Plasma Protein Products RFP Results, Transition Update and Discussion. CIPO Patient Events Feb-Apr 2018; July 2018
Canadian Blood Services: Plasma Protein Products RFP Results, Transition Update and Discussion CIPO Patient Events Feb-Apr 2018; July 2018 Outline Overview of our Plasma Protein Products Our business Procurement
More information3 Things Elite Healthcare Staffing Recruiters do that Separate the Best from the Rest LEAN HUMAN CAPITAL HEALTHCARESOURCE
3 Things Elite Healthcare Staffing Recruiters do that Separate the Best from the Rest 2017 LEAN HUMAN CAPITAL HEALTHCARESOURCE Healthcare Staffing - 2018 Healthcare Staffing - We re All Playing the Same
More informationDEVELOPING CLINICAL TRIALS INFRASTRUCTURE
DEVELOPING CLINICAL TRIALS INFRASTRUCTURE SESSION IV of IOM Workshop: Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020 PAUL EISENBERG PETRA KAUFMANN
More informationVALUE OF COMPANION DIAGNOSTICS IN PERSONALISED MEDICINE
VALUE OF COMPANION DIAGNOSTICS IN PERSONALISED MEDICINE Stimulating innovation for improving health through companion diagnostics 5 March 2015 I. Introduction Personalised healthcare provides targeted
More informationSUBJECT: INSTITUTIONAL REVIEW BOARD (IRB) - HUMANITARIAN USE DEVICES
This policy applies to the following entity(s): Children s Hospital of Wisconsin Children s Hospital and Health System, Inc. Administrative Policy and Procedure Children s Research Institute SUBJECT: INSTITUTIONAL
More informationBuilding a medical start up. Claudio Yarza, Pharma & Life Sciences Leader
www.pwc.com Building a medical start up Claudio Yarza, Pharma & Life Sciences Leader January 2016 Exit Report Slide 2 Lets start with the macro questions Does the global atmosphere make it easier to build
More informationFinancial Operations Track
Financial Operations Track Benchmarks and Decision Making in Financial Operation FACULTY DISCLOSURE The faculty reported the following financial relationships or relationships to products or devices they
More informationAn Integrated Approach to Patient Experience Analytics
An Integrated Approach to Patient Experience Analytics Director of Value Analytics Johns Hopkins Medicine Email: KLee31@jhmi.edu Vision, Mission, and Values Vision Enhance the value of health care services
More informationthe new era of responsibility CORPORATE RESPONSIBILITY REPORT
the new era of responsibility the pfizer commitment for today & tomorrow 11 THE NEW ERA OF RESPONSIBILITY Since our last corporate responsibility report in 2007, the world has changed dramatically. Although
More informationPCP experiences in Healthcare
PCP experiences in Healthcare EPP workshop, Suzan Ikävalko 12.5.2016 Agenda 1 Decipher mhealth PCP: Lessons learned 2 Case example: Noona ehealth services for cancer patients 3 Nordic PCP & PPI experiences
More information